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Abstract
The prostate gland is the only male accessory gland in dogs and is responsible 
for secreting the prostatic fluid. Morphologically, the canine prostate gland lacks 
differentiation into zones, presenting a uniform parenchyma along the longitudinal 
axis. The luminal epithelial cells secrete a liquid rich in calcium, citric acid, simple 
sugars, and different enzymes as a component of the seminal plasma. Since the pros-
tatic diseases are very common in small animal practice, there are many information 
regarding mechanisms of the different prostatic conditions and lack of information 
regarding the anatomy, histology, and physiology of the canine prostate gland. Thus, 
this chapter aims to meticulously describe the anatomy, histology, and physiology of 
the canine prostate gland.
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1. Introduction
The prostate gland is the only male accessory gland in dogs, having an important 
role in the secretion of seminal plasma components. It is a bilobed, oval gland located 
in the pelvic cavity of adult dogs through which passes the urethra and the vas defer-
ens, where the sperm are carried to the urethra. The prostate communicates with the 
urethra through several openings along the entire prostatic urethra through which the 
seminal plasma is secreted. Prostate diseases are extremely common in dogs, so their 
study is of great importance to better understand these conditions [1, 2]. The castra-
tion status is very important for the development of different prostatic disorders [3]. 
Usually, in developed countries, such as Canada, the United States, and Australia, the 
castration is very common. Due to castration and low levels of androgen hormones, 
the prostatic epithelium can be atrophic [1, 2]. On the other hand, the South America 
countries do not castrate dogs. Then, prostatic disorders such as benign prostatic 
hyperplasia (BPH) and prostatitis have high incidence [4]. Thus, the knowledge of 
the anatomy, histology, physiology, and pathology of the canine prostate gland is 
essential for the better approach of the canine patients.
2. Prostate gland anatomy
The prostate is a semioval bilobular exocrine gland that makes dorsal contact 
with the rectum, ventral with the pubic symphysis, lateral with the abdominal 
Veterinary Anatomy and Physiology
2
Figure 1. 
Canine normal prostate gland. Histological evaluation revealing a columnar epithelium distributed in one layer. 
The tissue stroma is composed by collagen fibers and fibroblasts. Hematoxylin and eosin (H&E) staining, 10×.
wall, and cranial with the bladder; its position may present slight variations 
depending on the age of the dog. Up to 2 months of age, the prostate is located in 
the caudal portion of the abdominal cavity; from this age until the animal reaches 
sexual maturity, the prostate is located in the pelvic cavity. After sexual maturity is 
reached, it increases in size cranially extending into the abdominal cavity [1, 2].
The sulcus dividing the right and left prostate lobes can be palpated dorsally by 
rectal palpation. Each lobe is subdivided into lobules by trabeculae; these are being 
formed by composed tubuloalveolar glands, and the ducts of these glands flow into 
the urethra throughout all its circumference. The prostatic urethra (part of the pelvic 
urethra that passes through the prostate) crosses the prostatic parenchyma slightly 
dorsally to its center. In addition, the prostate is covered by a fibromuscular tissue 
capsule, the prostate capsule [1, 2]. The vas deferens enters the prostate through 
the cranio-dorsal surface, and each one in a lobe traverses its parenchyma making a 
caudoventral path ending up in the urethra by the colliculus seminalis [1, 2].
The vascularization of the prostate is mainly due to the prostatic artery that 
originates from the internal pudendal artery. The prostatic artery gives rise to the 
middle rectal artery that branches and penetrates the prostatic capsule through 
the dorsolateral surface, becoming subcapsular vessels, until later they enter the 
prostate to provide the necessary blood supply to the glandular tissue. Anastomoses 
occur between the prostatic vessels and the urethral, cranial rectal, and caudal 
arteries, complicating prostatectomy [1, 2].
A venous blood is drained from the prostate by the prostatic and urethral veins 
to the internal iliac vein. The prostatic lymph vessels drain into the iliac lymph 
nodes. Prostatic innervation occurs through the hypogastric nerve (sympathetic 
system), which presents a path similar to the prostatic artery and the pelvic nerve 
(parasympathetic system). Glandular secretion is increased by parasympathetic 
stimuli [1, 2].
3. Prostate gland histology
The canine prostate is a morphologically homogeneous organ that does not 
differentiate into areas such as the human prostate and is mostly composed of 
secretory glandular tissue (Figure 1). The prostatic stroma that surrounds the 
prostatic urethra extends dorsally and ventrally to almost the limit of the prostate, 
whereas the lateral projections of the stroma are thinner. These stromal projections 
subdivide the prostate into several lobules of glandular epithelium. This epithe-
lium is mostly columnar that modifies to cuboid within the ductal structures of 
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the prostate; meanwhile the epithelium of the prostatic urethra may be cuboid or 
columnar, simple, or stratified [5].
The prostatic urethra passes through the prostate gland, showing an urothelial 
(transitional) epithelium, and the prostatic ducts have connection with the pros-
tatic urethra. Then, inflammatory cells infiltrating the prostatic stroma are common 
due to the constant antigenic stimulus related with ascended bacteria contamina-
tion of the urinary system. Thus, the prostatic stroma is composed by collagen 
fibers, fibroblast, smooth muscle (for prostatic contraction), and few mononuclear 
inflammatory cells. In dogs, the smooth muscle cells and the nerves are located in 
the peripheral region of this gland.
The basal or reserve cells are located in the basal cell layer in a discontinuous 
distribution (Figure 2). Usually, the luminal epithelial cells are positive for cyto-
keratin 8/18, pan-cytokeratin, NKX3.1, PTEN, and AR [3]. On the other hand, basal 
cells are positive for cytokeratin 5, p63, and high molecular weight cytokeratins 
(HMWC) [3].
4. Prostate gland physiology
The prostate is responsible for the production of most of the seminal plasma, 
which contains large amounts of proteins. One of the most studied proteins in 
humans, produced by both human and canine prostatic epithelia, is prostate-
specific antigen (PSA) [6]. The kallikrein-3 (KLK 3) gene encodes the PSA protein 
in humans, and dog genome lacks KLK 3 gene. In dogs, kallikrein-2 (canine 
prostate-specific arginine esterase, (CPSE) is a PSA homolog enzyme belonging to 
the serine-protease class [6]. This protein is normally secreted into the lumen of the 
prostate ducts and does not come into contact with the bloodstream in a prostate 
under physiological conditions. However, when there is a lesion that disrupts the 
prostate architecture, this protein can be found in the blood and may be an indica-
tor of a prostatic disease [7, 8].
Comparably to PSA, the canine prostate-specific arginine esterase (CPSE) is 
the most produced protein in the canine prostate and seems to be an alternative for 
the diagnosis of some prostatic conditions in dogs. Although the use of plasmatic 
markers as a diagnostic method for prostatic pathologies in human medicine is a 
commonplace in veterinary medicine, it is not a reality [7, 8].
Figure 2. 
Immunohistochemical evaluation of high molecular weight cytokeratin (HMWC) in a canine normal 
prostate gland. It is possible to identify positive membranous staining (brown color) in the basal cells, forming 
a discontinuous basal cell layer. The luminal cells are negative for the HMWC (blue staining). Harris 
hematoxylin counterstaining, 3 3’-diaminobenzidine tetrahydrochloride (DAB), 10×.
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The prostate depends on the testosterone that is produced in the testicles and 
converted into dihydrotestosterone (DHT) by the enzyme 5α-reductase. It is known 
that without this hormonal stimulus, the prostate will decrease its secretory func-
tion and volume. Castrated dogs lack testosterone, and consequently DHT will lead 
the prostate to a state of atrophy [7]. Thus, the endocrine control of the prostate 
gland, mainly by testis, is well characterized. In male dogs, the testosterone is the 
most important circulating androgen, and CYP19 (aromatase) can be metabolized 
into an estradiol-17β. The estrogen can affect the prostate gland growth and differ-
entiation. The role of androgen in prostatic development and pathological process is 
an understudied area.
5. Prostate gland disorders
5.1 Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is the most common prostatic pathology 
in dogs. There is a discordance among pathologists regarding the term “BPH.” 
Since hyperplasia is a term applied for a benign growth, using “benign” prostatic 
“hyperplasia” seems redundant. However, the term BPH is widely accepted in the 
international literature. Prostatic hyperplasia (PH) or BPH begins as a process of 
glandular hyperplasia that can occur around the age of 2–3 years. In intact dogs 
over 9 years, it affects more than 95% of the population [10]. This condition is part 
of the normal aging process and may include both hyperplastic and hypertrophic 
processes [1]. Histologically, the PH can be divided into two entities: glandular and 
complex hyperplasia.
PH is closely related to hormone stimulation in the prostate, indirectly by 
estrogen and directly by DHT, the former of which causes an increase in the recep-
tors for DHT, and DHT is directly responsible for prostatic growth when binding 
to epithelial cell receptors of the prostatic cells. In addition, older dogs can present 
high levels of testosterone production by the testicle that will be converted into 
DHT in the prostate [1, 9].
Many dogs affected by PH do not show clinical signs until the prostate is large 
enough to disrupt fecal flow through rectum compression. The most common 
clinical signs for PH are hematuria, constipation, blood-stained urethral discharge, 
and hemospermia [10]. The presumptive diagnosis of PH is usually performed by 
associating the patient’s clinical signs with the ultrasonography findings; however, 
for a definitive diagnosis, the histopathological examination of a prostatic sample is 
required [1]. The use of ultrasonography is indicated to aid in the evaluation of the 
extent of the lesion in which the prostate may present as a honeycomb due to the 
appearance of multiple cysts or as a symmetrical hyperplasia of the gland, which 
may or may not contain cysts [1, 10].
Neutering is still the most effective and recommended method of treatment of 
PH in most dogs with a 50–70% decrease in prostate volume at 3 weeks after the 
surgical procedure; however, the complete decrease of the prostate can take a month 
[10]. Surgery is contraindicated in cases where the risk of the procedure is too high or 
if the animal is used for reproduction. In these cases the drug treatment is indicated.
The most commonly used drug for the treatment of PH is finasteride, an inhibi-
tor of 5α-reductase, the enzyme responsible for the conversion of testosterone to 
DHT. This drug has been widely used in humans for more than 10 years. The use of 
finasteride decreases prostate volume by 43% after 16 weeks. Although the volume 
of the ejaculate decreases, the use of finasteride does not alter the seminal quality of 
the dogs or the libido and may be an option for breeding animals [11].
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There are other drugs that may be used as other options for the treatment of PH, 
such as progestogens, estrogens, analogues, and antagonists of GnRH, but they all 
have disadvantages when compared to finasteride, either concerning safety of the 
continuous use of the drug or cost of the drug [1].
5.2 Prostatic cysts
The appearance of prostatic cysts most often is related to PH. Cysts can be classified 
as intraprostatic or paraprostatic. Intraprostatic or retention cysts arise due to the clog-
ging of the prostatic gland ducts, causing the prostatic fluid to accumulate [9]. At the 
beginning of this condition, the cysts are very small and not detectable by ultrasonogra-
phy or rectal palpation, but with the evolution of the condition, many small cysts begin 
to communicate forming a large cavity that can be detected macroscopically [10, 12].
Paraprostatic cysts are closely associated with remnants of the uterus masculi-
nus, tend to be larger than intraprostatic ones, and can be palpated rectally or even 
transabdominally [1]. The clinical signs caused by prostatic cysts are very similar to 
the signs of conditions that cause an increase in prostatic volume, that is, they are 
reflex of the prostate pressing other structures that are located in the pelvis [12].
The diagnosis of prostatic cysts is performed by ultrasonography, but in cases 
where the cysts are very small, they may not be detected. The traditional treatment 
for prostatic cysts is surgical, by any of these techniques: surgical debridement, 
omentalization, marsupialization, placement of surgical drains, or partial prosta-
tectomy [10, 13, 14].
However, due to the risks of a surgical intervention, new techniques of ultra-
sound guided drainage are presented as viable options for the treatment of this 
affection [14].
5.3 Squamous metaplasia
Continuous stimulation of prostatic epithelial cells by estrogen may lead to 
squamous metaplasia. This estrogenic stimulus may be exogenous or endogenous 
[15]. The source of endogenous estrogen in animals with squamous metaplasia is the 
Sertoli cell neoplasia. As in PH, there is a trend toward the formation of prostatic 
cysts [10].
Squamous metaplasia (Figure 3) does not directly cause any clinical signs. This 
prostatic alteration is reversible if the endogenous or exogenous estrogen source is 
withdrawn [10].
Figure 3. 
Canine squamous metaplasia of the prostate gland. It is possible to observe a squamous differentiation of the 
prostatic epithelium, forming filaments of keratins in the lumen. An inflammatory infiltrate, composed by 
mononuclear cells, is also observed. Hematoxylin and eosin (H&E) staining, 20×.
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5.4 Prostatitis
Prostatitis is a prostate infection that affects mainly older dogs. The origin of the 
infection can be both ascending by the urinary tract and by hematogenous spread, 
the second case being rare. Other prostatic conditions such as PH or cysts may 
compromise the natural defense mechanisms of the prostate and may lead to the 
development of prostatitis [1, 10].
The most relevant microorganisms linked to prostatitis are Escherichia coli, 
Staphylococcus, Streptococcus spp., Mycoplasma spp., Proteus, Klebsiella spp., 
Pseudomonas aeruginosa, Enterobacter, Pasteurella spp., and Brucella canis. In rare 
cases, prostatitis can be caused by fungi [10, 12].
Prostatitis can be divided into two types: acute, in which the infection is more 
recent and the inflammatory process is more exacerbated and chronic, in which the 
clinical signs are milder.
The treatment of prostatitis should take into account some key factors for it 
to be successful. It is of extreme importance for the choice of the drug to evaluate 
the result of the culture of the prostatic fluid or semen; in addition, one should 
take into account the pharmacodynamics of the chosen active principle, since the 
prostate is a tissue of difficult penetration of the antibiotics due to the difference in 
pH between the prostate fluid and blood [1, 9].
Antibiotic treatment in the case of bacterial prostatitis should last for at least 
4 weeks, and a new culture of prostatic fluid and urine should be performed before 
the end of treatment so that it can be decided between completion and continua-
tion. A new culture test is also recommended 30 days after the end of treatment so 
that its success is confirmed [1].
Trimethoprim sulfa, chloramphenicol, and enrofloxacin are antibiotics that have 
good penetration into the prostatic tissue and are therefore good candidates for the 
treatment of bacterial prostatitis [16].
Castration is indicated as adjuvant therapy to reduce prostate volume and pre-
vent relapse; however, castration should not be performed during acute infection to 
avoid complications [16].
5.4.1 Acute prostatitis
In acute prostatitis, the infection is more recent, the inflammation is more 
intense, and the clinical signs presented are anorexia, fever, apathy, vomit, hypo-
gastric region pain, and preputial discharge. In addition, the complete blood count 
is a characteristic of an acute infectious process, with neutrophilia and left-sided 
deviation [1].
Diagnosis should be made based on the animal’s history and physical examina-
tion associated with exams such as transrectal prostate palpation, ultrasonography, 
complete blood count, urinalysis, and culture of prostate fluid or semen in cases 
where collection is possible [1].
In prostate palpation, it is common for the animal to present painful sensitivity 
due to the inflammatory process present there. In ultrasonography, the prostate will 
most often be enlarged, with its echogenicity increased, and may or may not have 
associated cysts or abscesses. Urine and semen will most often have neutrophils and 
bacteria present [1].
5.4.2 Chronic prostatitis
Unlike acute prostatitis, few chronic or no clinical signs are exhibited by the 
animal. The most common are recurrent urinary tract infections and bloody 
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urethral discharge. In addition, in rectal palpation, the prostate often has a 
normal volume, and the animal has no painful sensitivity. Because of this, the 
diagnosis in this case is more difficult and should be based on the clinical find-
ings associated with ultrasonography and culture of the prostatic fluid or semen 
[1, 9].
The difference of “acute” and “chronic” is usually a clinical classification, since 
both entities present a very divergent clinical signs, prognosis, and treatment. In a 
pathological “view,” inflammation is usually classified into focal or multifocal and 
according to the inflammatory infiltrate (cell type involved) and the presence or 
absence of intraluminal infiltration.
In humans, the chronic inflammatory infiltrate associated with the epithelial 
atrophy is described as a proliferative inflammatory atrophy (PIA) and is consid-
ered as a preneoplastic lesion [17]. In dogs, PIA is also found (Figure 4).
5.5 Prostatic abscesses
Prostatic abscesses can be consequences of prostatic cysts that become contami-
nated or of prostatitis. In the case of prostatitis, tissue inflammation can induce 
obstruction of the prostatic ducts, causing contaminated contents to accumulate 
resulting in an abscess [18].
The diagnosis is achieved through the association of history, clinical signs, and 
complementary tests. The signs of prostatic abscesses are related to the increased 
prostatic volume, the most common being tenesmus and dysuria. In addition, 
the animal may or may not feel pain during rectal palpation of the prostate. 
Ultrasonography and culture of the prostatic fluid are important tests for the 
diagnosis of prostatic abscesses [1, 14].
The treatment is based on draining the contents of the abscess. The most 
traditional ones are surgical intervention such as debridement and omentalization, 
marsupialization, subtotal prostatectomy, or placement of multiple penrose drains. 
However, due to the risks associated with these procedures, new approaches are 
emerging [14].
An alternative to the traditional surgical approach is the percutaneous drainage 
of the abscesses guided by ultrasonography, which in addition to being a cheaper 
technique than traditional surgery proved to be safe and effective. In addition, 
antibiotic therapy based on the result of prostatic fluid culture should be instituted 
in association with the technique chosen for drainage of the abscess [14].
Figure 4. 
Canine prostatic atrophic epithelium. There is atrophy of the glandular epithelium, disposed in two or more 
layers. There is an intense inflammatory mononuclear infiltrate and hemorrhage. Hematoxylin and eosin 
(H&E) staining, 10×.
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5.6 Prostatic neoplasia
Prostatic adenocarcinomas are a rare condition, affecting both castrated and 
non-castrated animals. They present a prevalence of 0.2–0.6% and have a predilec-
tion for animals with more advanced age, and the average age of an animal diag-
nosed with prostatic neoplasia is around 10 years [19]. Castrated dogs may present 
a greater chance of developing prostatic adenocarcinoma, being up to 2.38 times 
greater than non-castrated dogs [19]. In addition, prostatic carcinoma in dogs is 
androgen independent so castration is not a therapeutic possibility, except in cases 
associated with PH [16].
In the author’s experience, intact dogs present a higher prevalence of prostate 
cancer (PC), and this can be related to our dog population. Usually, castration is 
not performed in male dogs. Thus, we have a majority population of intact dogs. In 
a previous study of our research group [20], we have described a tumor phenotype 
in 90 canines with PC, and all dogs (90/90) were intact. We did not find any PC in 
a castrated dog, probably because in our dog population, castration is not routinely 
performed.
The clinical signs associated with prostatic carcinoma are dysuria, tenesmus, 
hematuria, anorexia, and weight loss. In addition, through transrectal palpation, 
the prostate is most often enlarged and asymmetric, and the animal may or may not 
present pain [16]. Complementary tests such as ultrasound and X-ray should always 
be required to assess the extent of the neoplasm in both the prostate and possible 
metastasis. Common radiographic findings are prostatic enlargement, prostatic 
mineralization, sublumbar lymphadenopathy, axial skeletal metastasis, pulmonary 
metastasis, and appendicular skeletal metastasis [19].
In ultrasonography, the most common findings are prostatic enlargement, pros-
tatic tissue mineralization, diffuse areas presenting hyperechogenicity, and irregular 
prostatic contour [19]. Areas of metastasis of prostatic carcinoma in descending order 
of incidence include the lungs, regional lymph nodes, liver, urethra, spleen, colon, 
rectum, urinary bladder, bones, heart, liver, and distal and adrenal lymph nodes [16].
The definitive diagnosis of prostatic carcinoma is made by means of cytol-
ogy or prostate biopsy. Both techniques can be performed transabdominally with 
the aid of ultrasonography. There are different histological subtypes of prostatic 
adenocarcinoma, and the major challenge is the differentiation between urothelial 
and luminal origins of the undifferentiated subtypes. The castrated dogs are more 
prone to develop the most undifferentiated kinds of neoplasms and seem difficult 
Figure 5. 
Canine prostate cancer. (A) Low-grade canine prostate cancer (Gleason score 6) composed by small glandular 
proliferation with tubules showing more than two layers with evident nucleoli. Hematoxylin and eosin (H&E) 
staining, 10×. (B) High-grade prostate cancer (Gleason score 8), showing moderate anisokaryosis, evident 
nucleoli, and mitosis. Hematoxylin and eosin (H&E) staining, 40×.
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Figure 6. 
Gross morphology of two canine prostate cancers. (A) Infiltrative prostate cancer, with the prostate gland 
showing a heterogeneous parenchyma, cystic areas, and necrosis. (B) A serial section of a prostate gland with a 
canine prostate cancer showing a well-delimited mass (arrows).
Figure 7. 
Protein-protein interaction (PPI) analysis using the canine data (copy number alteration provided by Amorim 
et al. [27]) and the human prostate cancer data from The Cancer Genome Atlas (TCGA). It is possible to 
evaluate the connectivity degree between gene alterations in human and dogs (triangles). Genes with deletion 
frequency higher than 30% (red triangles) and genes with developed drug targets are also observed.
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to differentiate an undifferentiated prostatic adenocarcinoma from an undiffer-
entiated prostatic urothelial carcinoma [21]. Recently, the Gleason score was also 
proposed in canine prostatic pathology (Figure 5) [22].
Morphologically, canine PC can present an infiltrative growth pattern or form 
a prostatic mass (Figure 6). The infiltrative pattern can be difficult to differenti-
ate from other prostatic diseases such as prostatitis and PH. Thus, in these cases, 
ultrasound examination can be challenging.
The treatment of prostatic adenocarcinoma is most often ineffective, making it 
palliative rather than curative. In addition, in most cases the diagnosis is made only 
at an advanced stage of the disease, making the prognosis even more reserved [1]. 
The results of chemotherapy and surgical protocols in cases of prostatic adeno-
carcinoma are unsatisfactory, not prolonging the life expectancy of the patient. 
Radiotherapy may be an option in cases where increased prostatic volume due to 
the tumoral mass is a problem for the animal, since this therapeutic option can 
cause reduction of the prostate volume but without increase in life expectancy [8].
Another important point to consider is if the animal is neutered or not. 
Castration or the use of finasteride may help in reducing the prostatic volume but 
Figure 8. 
Ingenuity pathway analysis (IPA) of the canine copy number alteration data published by Amorim et al. [27]. 
Disruption of the ILK signaling pathway. Genes in green present a significant copy number loss compared to 
normal tissue.
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without influence on the tumor mass. Due to the poor prognosis of this condition, 
usually euthanasia must be taken into consideration [1].
The genomic profiling of canine PC is poorly explored. Few previous studies have 
evaluated the genomic of transcriptomic alterations in canine PC. In human, the 
molecular subtype of the PC is very important for the patient prognosis. The recur-
rent SPOP, FOXA1, and IDH1 mutations, genic fusions (ERG, ETV1/4, and FLI1), 
activated PI3K/AKT/mTOR and MAPK pathway mutations, and germ line or somatic 
DNA-repair gene mutations (including BRCA1/2, CDK12, ATM, FANCD2, and 
RAD51C) (~20% of primary PC) represent different subtypes of human PC [23].
Canine molecular alteration in E-cadherin, Caveolin-1, APC and β-catenin [24], 
NKX3.1 and c-Myc [3], c-KIT [25] and PTEN, TP53, MDM2, and AR expression 
[26] was previously described in literature. However, these studies have evalu-
ated only gene expression. A recent study from our research group investigated 
the copy number alterations in canine PC [27]. We identified copy number loss 
in TP53 and PTEN and gain of MDM2, indicating the role of the TP53 pathway 
in the development of canine PC. Moreover, we identified many drug targets in 
canine PC, including VEGF and HER-2 (Figure 7) and imbalances in ILK signaling 
pathway (Figure 8).
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